BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34181023)

  • 1. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases.
    Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S
    QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
    Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
    Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis.
    Arora R; Goel R; Meher R
    JAMA Ophthalmol; 2022 May; 140(5):548. PubMed ID: 35389467
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.
    Date PS; Choksi T; Ingole AB
    JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457
    [No Abstract]   [Full Text] [Related]  

  • 5. Rhino-Orbital-Cerebral Mucormycosis-Another Deadly Complication of COVID-19 Infection.
    Tooley AA; Bradley EA; Woog JJ
    JAMA Ophthalmol; 2022 Jan; 140(1):73-74. PubMed ID: 34882174
    [No Abstract]   [Full Text] [Related]  

  • 6. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding.
    Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK
    Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhino-orbital mucormycosis in a COVID-19 patient.
    Baskar HC; Chandran A; Reddy CS; Singh S
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167998
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
    Naik MN; Rath S
    Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-Related Rhino-Orbital-Cerebral Mucormycosis in a Renal Transplant Recipient.
    Gökbulut Bektaş Ş; Kandemir AB; Ayaz ÇM; Yilmaz AN; İzdeş S
    Exp Clin Transplant; 2022 Feb; 20(2):213-217. PubMed ID: 34981710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on: Case series of central retinal artery occlusion in COVID-19-associated rhino-orbito-cerebral mucormycosis.
    Kamath GM; Jeganathan S; Salim S; Antony RM; Kamath AR; Hiran H
    Indian J Ophthalmol; 2024 May; 72(5):755-756. PubMed ID: 38648440
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.
    Mekonnen ZK; Ashraf DC; Jankowski T; Grob SR; Vagefi MR; Kersten RC; Simko JP; Winn BJ
    Ophthalmic Plast Reconstr Surg; 2021 Mar-Apr 01; 37(2):e40-e80. PubMed ID: 33229953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
    Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
    Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis in COVID-19 patients.
    Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
    Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report.
    Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M
    Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features.
    Rao R; Shetty AP; Nagesh CP
    Indian J Ophthalmol; 2021 Jun; 69(6):1627-1630. PubMed ID: 34011758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
    Kaur K; Gurnani B
    Indian J Pharmacol; 2021; 53(5):417-419. PubMed ID: 34854414
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression is a Double-Edged Sword in COVID-19 Treatment: a Case Report of Rhino-Orbito-Cerebral Mucormycosis.
    Sedaghattalab M; Bagheri T; Doustimotlagh AH
    Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.